Kiromic Biopharma, Inc.·4

Oct 6, 4:05 PM ET

Hungerford Brian 4

4 · Kiromic Biopharma, Inc. · Filed Oct 6, 2023

Insider Transaction Report

Form 4
Period: 2023-10-05
Transactions
  • Award

    Restricted Stock Units

    2023-10-05+21,90021,900 total
    Common Stock (21,900 underlying)
Footnotes (1)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. All of the RSUs vest on October 1, 2024 provided that the Reporting Person remains in continuous service on each vesting date.

Documents

1 file
  • 4
    tm2327977-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT